KVK-Tech Recalls Oxybutynin Chloride Tablets Due to Wrong Bar Code
KVK-Tech, Inc. is recalling 156 bottles of Oxybutynin Chloride Tablets, 5 mg, because they bear the wrong bar code.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a minor labeling error (wrong bar code) with no reported illnesses or injuries, fitting the 'Moderate' criteria for minor labeling errors.
Plain-English summary
KVK-Tech, Inc. is recalling 156 bottles of Oxybutynin Chloride Tablets, USP, 5 mg, 500-count bottle, Rx only. The product is identified by NDC 10702-201-50, Lot # 15079A, and an expiration date of 10/20.
The recall was initiated because the product bears the wrong bar code. This is a labeling error.
The product was distributed by 10 major distributors throughout the United States. Consumers and healthcare providers should check their inventory for this specific lot and NDC number. If found, the product should be returned to the distributor or the recalling firm.
The recalled product
- Product
- OXYBUTYNIN CHLORIDE (OXYBUTYNIN CHLORIDE)
- Brand
- OXYBUTYNIN CHLORIDE
- Manufacturer
- KVK-Tech, Inc.
- Category
- Drug — Prescription Drug
- Hazard
- Affected units
- 156
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 15079A
- Exp 10/20
Distribution
Distribution scope not specified by the agency.
Related recalls
Same brand · OXYBUTYNIN CHLORIDE
- LowAvKARE Recalls Oxybutynin Chloride Tablets for Failed Dissolution Specifications
FDA (Drugs) · 2019-03-20
- ModerateLannett Recalls Oxybutynin Chloride Tablets for Dissolution Failures
FDA (Drugs) · 2019-03-20
Same manufacturer · KVK-Tech, Inc.
See all →- ModeratePhentermine Hydrochloride Capsules 30mg Recalled for cGMP Deviations
FDA (Drugs) · 2025-05-28
- ModerateIndomethacin Extended-Release Capsules Recalled for cGMP Deviations
FDA (Drugs) · 2025-05-28
- SevereBetaxolol Hydrochloride tablets recalled due to oxycodone contamination
FDA (Drugs) · 2023-10-25
- SevereAtovaquone Oral Suspension Recalled for Temperature Abuse
FDA (Drugs) · 2021-09-01
- ModerateKVK-Tech Recalls Hydrocodone and Homatropine Tablets for Impurity Failures
FDA (Drugs) · 2021-05-26
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02